EyePoint Pharmaceuticals, Inc. — Director's Dealing 2011

Jul 25, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2011-07-21

Reporting Person: Freedman Lori (VP Corp Affairs,Gen Coun & Sec)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-07-21	Employee Stock Option (right to buy)	$5.05	A	60000	Acquired	2021-07-21	Common Stock (60000)	Direct

Footnotes

F1: The option becomes exercisable in four equal annual installments beginning on the first anniversary of the date of grant.